Policy moves fast. You shouldn’t have to chase it.
Welcome back! After a long holiday weekend, the cannabis and hemp policy landscape didn’t take a break. Federal researchers are still trapped in a Schedule I paradox, unable to gather the evidence regulators say they need. In Massachusetts, lawsuits are the next forum for lab issues. Canada just seized $26 million in product after compliance sweeps, and Thailand reversed its brief experiment with legalization in favor of prescription-only access.
The lesson across jurisdictions is the same: cannabis markets live and die on regulatory design, and even small policy shifts can reset the board for operators and investors overnight.
☕ Read this with your morning coffee.
📈 Reference it in your strategy meeting.
📬 Forward it to your compliance lead.
Start smarter. Move faster. Stay ahead.